Other Clinical Trial - Clinical Trial to Assess Efficacy of cYclosporine

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04463758` - Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns
Recruiting	`NCT05911100` - State of Oxygen Metabolism, Cardiovascular and Respiratory System Reserve Capacity in Patients Who Underwent COVID-19
Not yet recruiting	`NCT06355232` - Covid-19 and Influenza Oral Vaccine Study	Phase 1
Terminated	`NCT04359862` - Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection	Phase 4

See also

Status

Clinical Trial

Phase

Recruiting

NCT04463758 - Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

Recruiting

NCT05911100 - State of Oxygen Metabolism, Cardiovascular and Respiratory System Reserve Capacity in Patients Who Underwent COVID-19

Not yet recruiting

NCT06355232 - Covid-19 and Influenza Oral Vaccine Study

Phase 1

Terminated

NCT04359862 - Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04392531
Study type	Interventional
Source	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Contact
Status	Completed
Phase	Phase 4
Start date	April 16, 2020
Completion date	March 31, 2021

Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms